| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 5,802,000 | 5,668,000 | 6,546,000 | 6,808,000 | | Cost of Revenue | 3,781,000 | 3,731,000 | 5,022,000 | 5,154,000 | | | Gross Profit | 2,021,000 | 1,937,000 | 1,524,000 | 1,654,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 834,000 | 829,000 | 879,000 | 931,000 | | Non Recurring | 127,000 | 83,000 | 1,995,000 | (60,000) | | Others | 367,000 | 343,000 | 382,000 | 374,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 693,000 | 682,000 | (1,732,000) | 409,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 693,000 | 682,000 | (1,732,000) | 409,000 | | Interest Expense | 173,000 | 164,000 | 186,000 | 144,000 | | Income Before Tax | 520,000 | 518,000 | (1,918,000) | 265,000 | | Income Tax Expense | 348,000 | 230,000 | (112,000) | 118,000 | | Minority Interest | 4,000 | (4,000) | 12,000 | (3,000) | | | | Net Income From Continuing Ops | 144,000 | 257,000 | (1,796,000) | 149,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| 5,000 |
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 144,000 | 257,000 | (1,791,000) | 149,000 | | Preferred Stock And Other Adjustments | (8,000) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $136,000 | $257,000 | ($1,791,000) | $149,000 |
|
0.20% Nasdaq 
0.14%
Income Statement
